UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549


                                  SCHEDULE 13D



                    Under the Securities Exchange Act of 1934
                             (Amendment No. 2 )*
                                           ---


                           Senesco Technologies, Inc.
                           --------------------------
                                (Name of Issuer)


                          Common Stock, $0.01 par value
                          -----------------------------
                         (Title of Class of Securities)


                                   817208 40 8
                                   -----------
                                 (CUSIP Number)


   Joel Brooks, 303 George Street, Suite 420, New Brunswick, New Jersey 08901
   --------------------------------------------------------------------------
                                 (732-296-8400)
                                 --------------
 (Name, Address and Telephone Number of Person Authorized to Receive Notices and
                                 Communications)


                                December 31, 2002
                                -----------------
             (Date of Event Which Requires Filing of this Statement)


If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  that is the subject of this  Schedule  13D, and is filing this
schedule  because of Rules 13d-1(e),  13d-1(f) or 13d-1(g),  check the following
box. |_|

Note.  Schedules  filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any  subsequent  amendment  containing  information  which  would  alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).


                                Page 1 of 6 Pages



- --------------------------------                 -------------------------------
    CUSIP No. 817208 40 8              13D              Page 2 of 6 Pages
             ------------                                    --   --
- --------------------------------                 -------------------------------

- --------------------------------------------------------------------------------
   1      NAMES OF REPORTING PERSONS
          I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

          Phillip O. Escaravage
          ---------------------        -------------------
- --------------------------------------------------------------------------------
   2      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
          (SEE INSTRUCTIONS)                                        (a) |_|
                                                                    (b) |_|
- --------------------------------------------------------------------------------
   3      SEC USE ONLY

- --------------------------------------------------------------------------------
   4      SOURCE OF FUNDS (SEE INSTRUCTIONS)          PF
- --------------------------------------------------------------------------------
   5      CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
          PURSUANT TO ITEM 2(d) or 2 (e)                                |_|
- --------------------------------------------------------------------------------
   6      CITIZENSHIP OR PLACE OF ORGANIZATION

               Canada
          -----------------
- --------------------------------------------------------------------------------
   NUMBER OF      7    SOLE VOTING POWER              816,352   (See Item 5)
                                                    -----------
    SHARES     -----------------------------------------------------------------

 BENEFICIALLY     8    SHARED VOTING POWER              N/A

   OWNED BY    -----------------------------------------------------------------

     EACH         9    SOLE DISPOSITIVE POWER         816,352   (See Item 5)
                                                    -----------
   REPORTING   -----------------------------------------------------------------

  PERSONS WITH   10    SHARED DISPOSITIVE POWER         N/A
- --------------------------------------------------------------------------------
   11     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

              816,352   (See Item 5)
             ---------
- --------------------------------------------------------------------------------
   12     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
          CERTAIN SHARES (SEE INSTRUCTIONS)                             |_|
- --------------------------------------------------------------------------------
   13     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11             6.83%
                                                                       -----
- --------------------------------------------------------------------------------
   14     TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)                    IN
- --------------------------------------------------------------------------------




 ITEM 1.       SECURITY AND ISSUER.

               The  title  of the  class of  equity  securities  to  which  this
               statement  relates is common stock,  $0.01 par value (the "Common
               Stock"), of Senesco  Technologies,  Inc., a Delaware  corporation
               (the "Company").  The address of the principal  executive offices
               of the Company is 303 George  Street,  Suite 420, New  Brunswick,
               New Jersey 08901.

 ITEM 2.       IDENTITY AND BACKGROUND.

               This  statement  on  Schedule  13D is being  filed by  Phillip O.
               Escaravage,  the sole member of The Umbrella  Project,  L.L.C., a
               New Jersey limited liability company ("Umbrella"). The address of
               Umbrella's principal place of business and principal office is 95
               Old Dutch Road, Far Hills, New Jersey 07931. Umbrella's principal
               business  is a holding  company  which  invests  in a variety  of
               business entities conducting various  activities.  Mr. Escaravage
               is a citizen of Canada but a resident alien of the United States.

               During the last five years,  neither Umbrella nor Mr.  Escaravage
               has been convicted in a criminal  proceeding  (excluding  traffic
               violations or similar misdemeanors), and neither Umbrella nor Mr.
               Escaravage  was a party to a civil  proceeding  of a judicial  or
               administrative  body of  competent  jurisdiction  as a result  of
               which  proceeding  it was or is subject to a judgment,  decree or
               final order  enjoining  future  violations  of, or prohibiting or
               mandating activities subject to, federal or state securities laws
               or finding any violation with respect to such laws.

 ITEM 3.       SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

               On October  9,  1998,  Senesco,  Inc.,  a New Jersey  corporation
               ("Senesco"),   Nava  Leisure  USA,  Inc.,  an  Idaho  corporation
               ("Nava"),   Nava  Leisure   Acquisition   Corp.,   a  New  Jersey
               corporation and wholly-owned  subsidiary of Nava ("NAC"), and the
               Principal  Stockholders  (as defined  therein),  entered  into an
               Agreement  and Plan of  Merger,  providing  for the merger of NAC
               with and into Senesco,  and the issuance to the  shareholders  of
               Senesco one newly  issued  share of Common Stock of Nava for each
               share of Common  Stock of Senesco  whereby  the  shareholders  of
               Senesco acquired a majority of the issued and outstanding  shares
               of  Common  Stock  of  Nava  (the   "Merger").   The  Merger  was
               consummated  on  January  22,  1999,  the  date  upon  which  the
               Certificate  of Merger  filed with the  Secretary of State of the
               State of New Jersey was declared effective. Upon the consummation
               of the Merger, Senesco was the surviving corporation and remained
               a  subsidiary   of  Nava  which   changed  its  name  to  Senesco
               Technologies, Inc., an Idaho corporation ("STI").

               Umbrella  was a  shareholder  of Senesco and  beneficially  owned
               933,476  shares of Common  Stock of  Senesco.  As a result of the
               Merger, on January 22, 1999,  Umbrella received 933,476 shares of
               Common Stock of STI (formerly Nava),  consisting of 34.57% of the
               2,700,008 shares of STI Common Stock issued and outstanding.

               On September 7, 1999,  STI granted to Mr.  Escaravage  options to
               purchase 40,000 shares of STI Common Stock, on a post stock split
               adjusted basis (as described  below),  at an exercise price equal
               to $3.85 per  share.  Mr.  Escaravage  received  such  options as
               consideration  for his  services as a Director  of STI.  All such
               options are currently exercisable.

               On September 29, 1999,  STI declared a two-for-one  forward stock
               split of its  issued  and  outstanding  Common  Stock  and,  as a
               result,  Umbrella's  holdings of STI Common  Stock  increased  to
               1,866,952 shares, excluding any options to purchase shares of STI
               Common Stock.

               On September 30, 1999, STI merged with and into the Company,  for
               the sole  purpose of  reincorporating  the  corporation  from the
               State of Idaho to the State of Delaware.

               On  December  1, 2001,  the  Company  granted  to Mr.  Escaravage
               options to purchase 40,000 shares of Common Stock pursuant to the
               Company's 1998 Stock Incentive  Plan, as amended,  at an exercise
               price  of  $2.26  per  share,  for his  services  performed  as a
               director of the  Company.  One-half  (1/2) of such  options  were
               exercisable  on the  date of  grant  and  one-half  (1/2) of such
               options became exercisable on December 1, 2002.

                               Page 3 of 6 Pages




 ITEM 4.       PURPOSE OF TRANSACTION.

               On April 16, 2002,  Umbrella  sold 34,737  shares of Common Stock
               pursuant to a private resale to an unrelated third party.

               On December 1, 2002, one-half (1/2) of the 40,000 options granted
               to Mr.  Escaravage  on December 1, 2001 pursuant to the Company's
               1998 Stock Incentive Plan, as amended, at an exercise price equal
               to $2.26 per share, became exercisable.

               Umbrella and/or Mr.  Escaravage may from time to time,  depending
               upon market  conditions,  the state of affairs of the Company and
               other factors,  acquire  additional shares of Common Stock of the
               Company,  subject to applicable  laws and to the  availability of
               shares at prices deemed favorable. Alternatively, Umbrella and/or
               Mr.  Escaravage  may  dispose of shares of the  Company's  Common
               Stock.  Umbrella and/or Mr.  Escaravage will continue to consider
               their respective equity interests in the Company and they reserve
               the right to formulate such plans or proposals,  and to take such
               action, as may seem appropriate in light of future circumstances.

               Except as set forth above,  neither  Umbrella nor Mr.  Escaravage
               have any present  plans or  intentions  which would  result in or
               relate to any of the following:

               (a)  The  acquisition  by any person of additional  securities of
                    the  Company,  or  the  disposition  of  securities  of  the
                    Company;

               (b)  An extraordinary  corporate  transaction,  such as a merger,
                    reorganization or liquidation, involving the Company;

               (c)  A sale or  transfer  of a  material  amount of assets of the
                    Company;

               (d)  Any change in the present  board of directors or  management
                    of the Company,  including  any plans or proposals to change
                    the  number or terms of  directors  or to fill any  existing
                    vacancies on the board;

               (e)  Any  material  change  in  the  present   capitalization  or
                    dividend policy of the Company;

               (f)  Any other  material  change  in the  Company's  business  or
                    corporate structure;

               (g)  Changes  in the  Company's  charter,  bylaws or  instruments
                    corresponding  thereto or other actions which may impede the
                    acquisition of control of the Company by any person;

               (h)  Causing a class of  securities of the Company to be delisted
                    from  a  national  securities  exchange  or to  cease  to be
                    authorized to be quoted in an inter-dealer  quotation system
                    of a registered national securities association;

               (i)  A  class  of  equity  securities  of  the  Company  becoming
                    eligible for termination of registration pursuant to Section
                    12(g)(4) of the Act; or

               (j)  Any action similar to any of those enumerated above.

 ITEM 5.       INTEREST IN SECURITIES OF THE ISSUER.

               (a)  Mr.  Escaravage is the beneficial owner of 816,352 shares of
                    Common Stock, including options to purchase 80,000 shares of
                    Common Stock.  Umbrella is the  beneficial  owner and record
                    holder of 736,352 shares of Common Stock.  Mr.  Escaravage's
                    816,352  shares  of  Common  Stock  represents  6.83% of the
                    issued and outstanding shares of Common Stock of the Company
                    as of December 31, 2002,  based on 11,880,045  shares issued
                    and  outstanding  and  assuming  the exercise of all options
                    exercisable within 60 days held by Mr. Escaravage.  Umbrella
                    disclaims any beneficial interest in the options to purchase
                    shares of Common  Stock held by Mr.  Escaravage.  Umbrella's
                    736,352  shares  of  Common  Stock  represents  6.20% of the
                    issued and outstanding shares of Common Stock of the Company
                    as of December 31, 2002,  based on 11,880,045  shares issued
                    and outstanding.

                    Mr.  Escaravage  is  the  beneficial  owner  of  options  to
                    purchase  80,000  shares of Common  Stock,  all of which are
                    presently exercisable. The options to purchase 80,000 shares
                    of Common Stock held by Mr. Escaravage  represents less than
                    1% of the issued and  outstanding  shares of Common Stock of
                    the  Company,   based  on   11,880,045   shares  issued  and
                    outstanding  as of December 31,  2002.


                                  Page 4 of 6


               (b)  Umbrella  has the sole  power to vote and the sole  power to
                    dispose of 736,352 shares of Common Stock held solely by it.
                    Mr. Escaravage has the sole power to vote and the sole power
                    to dispose of options to  purchase  80,000  shares of Common
                    Stock held solely by him.

               (c)  During 2002, the percentage of issued and outstanding Common
                    Stock  beneficially  owned by Mr. Escaravage was reduced due
                    to (i)  Umbrella's  sale and  transfer  of 34,737  shares of
                    Common  Stock  to an  unrelated  third  party,  and (ii) the
                    Company's private placements of Common Stock.

               (d)  No other person is known to have the right to receive or the
                    power to  direct  the  receipt  of  dividends  from,  or the
                    proceeds from the sale of, such securities.

               (e)  Not applicable.

 ITEM 6.       CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH THE
               ISSUER.

               There is no contract, arrangement,  understanding or relationship
               (legal  or  otherwise)  between  Umbrella  and the  Company  with
               respect  to any  securities  of the  Company,  including  but not
               limited to, transfer of voting of any of the securities, finder's
               fees, joint ventures, loan or option arrangements, puts or calls,
               guarantees of profits, division of profits or loss, or the giving
               or withholding of proxies.

 ITEM 7.       MATERIAL TO BE FILED AS EXHIBITS.

               None.


                               Page 5 of 6 Pages



                                    SIGNATURE

After  reasonable  inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.



February 18, 2003          /s/ Phillip O. Escaravage
                           -----------------------------------
                           Phillip O. Escaravage, Stockholder


The  original  statement  shall be signed by each  person  on whose  behalf  the
statement is filed or his authorized representative.  If the statement is signed
on behalf of a person by his authorized  representative (other than an executive
officer  or  general   partner  of  the   filing   person),   evidence   of  the
representative's  authority to sign on behalf of such person shall be filed with
the  statement,  provided,  however,  that a power of attorney  for this purpose
which is already on file with the Commission may be  incorporated  by reference.
The name and any title of each person who signs the statement  shall be typed or
printed beneath his signature.

ATTENTION:  INTENTIONAL  MISSTATEMENTS  OR OMISSIONS OF FACT CONSTITUTE  FEDERAL
CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).


                               Page 6 of 6 Pages